|1.||Wack, Séverine: 3 articles (06/2007 - 03/2004)|
|2.||Deharvengt, Sophie: 3 articles (06/2007 - 03/2004)|
|3.||Hajri, Amor: 3 articles (06/2007 - 03/2004)|
|4.||Aprahamian, Marc: 3 articles (06/2007 - 03/2004)|
|5.||Tu, Ya-Qin: 1 article (06/2013)|
|6.||Huang, Ge-Ling: 1 article (06/2013)|
|7.||Jiang, Yu: 1 article (06/2013)|
|8.||Chen, Zhi-Hao: 1 article (06/2013)|
|9.||Dai, Wu-Xing: 1 article (06/2013)|
|10.||Kern, Selina: 1 article (06/2011)|
08/05/2007 - "In this study we examined the efficacy of ePNP under the control of hTERT promoter sequences and assessed the selective killing effects of the ePNP/prodrug MePdR system on pancreatic tumors. "
07/01/2008 - "Our data support a hopeful view that tumor-targeting SC36 could improve antitumor efficacy of the ePNP/MePdR system due to its preferential accumulation and anticancer activity in tumors."
05/01/2005 - "These data confirm and extend the antitumor efficacy of the ePNP/MePdR killing system and demonstrate the feasibility of the transcriptional targeting strategy under tumor marker promoter control and thereby a preferential killing of CEA- and MUC1-producing pancreatic tumor cells. "
06/01/2013 - "These findings suggest that the SL/pShT-ePNP system may serve as a powerful strategy for tumor therapy."
06/01/2013 - "SL/pShT-ePNP and F-dAdo were also found to exert powerful therapeutic effects in combination against tumor growth and for prolonging the lifespan of tumor-bearing mice. "
06/01/2008 - "SC/ePNP was given orally to mice bearing mammary carcinomas, and its antitumor effect was evaluated. "
05/01/2005 - "coli purine nucleoside phosphorylase (ePNP) is under the control of either CEA or MUC1 promoter sequences and to investigate on experimental pancreatic carcinomas the selective killing effects of the conditional ePNP/prodrug (MePdR) system. "
06/01/2007 - "The aim of this study was to demonstrate the potential of electrogene therapy with the bacterial purine nucleoside phosphorylase gene (ePNP), on pancreatic carcinoma (PC) large tumors. "
|3.||Pancreatic Neoplasms (Pancreatic Cancer)
08/05/2007 - "The ePNP/MePdR system affects SW1990 human pancreatic cancer cell lines in vitro. "
03/01/2004 - "A recombinant pCAG-ePNP vector was constructed and used to establish pancreatic cancer cells expressing constitutively ePNP (ePNP+). "
08/05/2007 - "The hTERT promoter control of the ePNP/MePdR system can provide a beneficial anti-tumor treatment in pancreatic cancer cell lines including a good bystander killing effect."
03/01/2004 - "The ePNP/MePdR system effects were tested in vitro on HA-RPC (rat) and BxPC3 (human) pancreatic cancer cell lines and then in vivo on tumors established in nude mice with BxPC3 ePNP+ cells. "
|4.||Wounds and Injuries (Trauma)
|5.||Melanoma (Melanoma, Malignant)
|3.||Serine Proteases (Serine Protease)
|6.||Tosyllysine Chloromethyl Ketone
|7.||Protease Inhibitors (Protease Inhibitor)
|9.||Glutathione (Reduced Glutathione)
|10.||Epoxy Compounds (Epoxides)
|1.||Heterologous Transplantation (Xenotransplantation)